The changes in human lifestyle over the past few decades have impacted the prevalence of
skin diseases within different societies. Skin diseases may result in various physical and …

Background All the scoring methods for the DLQI miss the moderate impact of the disease
on patients, which may underestimate the impact of psoriasis on patients' quality of life. To …

Skin diseases are prevalent globally and can have detrimental effects on the individual's
health-related quality of life (HRQoL). The treatment of dermatological patients typically …

Background Psoriasis is a chronic erythematous inflammatory skin disorder. The major
challenge with psoriasis is delayed diagnosis, resulting in delayed treatment initiation and …

Background Ustekinumab is an interleukin (IL)-12/IL-23 inhibitor for the treatment of
moderate-to-severe psoriasis. Objective This real-world study compared ustekinumab and …

Recent advances in biologic treatments have made clear skin a realistic treatment goal for
psoriasis. However, clear skin may not uniformly translate to an absence of impact on …

Psoriasis is a disease that negatively affects the quality of life and is commonly seen
together with depression and anxiety. In this study, the relationships between the …

Background: We aimed to identify the quality of life (QoL) of patients with psoriasis, to
determine the possible differences depending on the therapeutic modalities (biologic …

Uvod: Studija je imala za cilj proceniti kvalitetu života pacijenata obolelih od psorijaze, te
istražiti razlike u zavisnosti od vrste primenjivanog terapijskog modaliteta (biološka …

Особенности течения заболевания, качества жизни и цитокинового профиля у пациентов с
вульгарным псориазом в стационарной стадии и коморбидной депрессией | Горлова …